PARK7 and Parkinson disease: The increase in plasma hsa‐miR‐4639‐5p level in PD patients likely contributes to the pathogenesis of PD through downregulating DJ‐1 expression and impairing the antioxidative stress ability of neurons (Chen et al., 2017).